Status:
RECRUITING
Evaluation of Endoscopic Ultrasound Shear Wave Elastography (EUS-SWE) for the Diagnosis of Pancreatic Adenocarcinoma.
Lead Sponsor:
GCS Ramsay Santé pour l'Enseignement et la Recherche
Conditions:
Pancreas Cancer
Eligibility:
All Genders
18+ years
Brief Summary
To assess the diagnostic accuracy of Shear Wave elastography (SWE) for the diagnosis of pancreatic adenocarcinoma.
Detailed Description
Pancreatic adenocarcinoma (PA) is the most common tumor of the pancreas, representing more than 90% of all solid pancreatic neoplasia and 55% -73% of solid pancreatic masses. Given its poor prognosis...
Eligibility Criteria
Inclusion
- Patient over 18 years of age
- Patient with a solid pancreatic mass of indeterminate origin
Exclusion
- Patient with ASA score 4 or 5
- Patient with contraindication to SonoVue injection
- Protected patient : major under guardianship, tutorship or other legal protection, deprived of liberty by judicial or administrative decision
Key Trial Info
Start Date :
September 21 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT04851106
Start Date
September 21 2021
End Date
December 1 2025
Last Update
April 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Jean Mermoz
Lyon, France, 69008